JP2006514034A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514034A5
JP2006514034A5 JP2004562241A JP2004562241A JP2006514034A5 JP 2006514034 A5 JP2006514034 A5 JP 2006514034A5 JP 2004562241 A JP2004562241 A JP 2004562241A JP 2004562241 A JP2004562241 A JP 2004562241A JP 2006514034 A5 JP2006514034 A5 JP 2006514034A5
Authority
JP
Japan
Prior art keywords
blood cells
blood
cultured
use according
interleukin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004562241A
Other languages
English (en)
Japanese (ja)
Other versions
JP4863620B2 (ja
JP2006514034A (ja
Filing date
Publication date
Priority claimed from US10/159,148 external-priority patent/US7048922B2/en
Application filed filed Critical
Publication of JP2006514034A publication Critical patent/JP2006514034A/ja
Publication of JP2006514034A5 publication Critical patent/JP2006514034A5/ja
Application granted granted Critical
Publication of JP4863620B2 publication Critical patent/JP4863620B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004562241A 2002-05-29 2003-05-07 抹消血単核細胞の培養方法及び該細胞を用いた薬剤組成物 Expired - Fee Related JP4863620B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/159,148 2002-05-29
US10/159,148 US7048922B2 (en) 2002-05-29 2002-05-29 Stimulation of hematopoiesis by ex vivo activated immune cells
PCT/US2003/014336 WO2004056397A1 (en) 2002-05-29 2003-05-07 Stimulation of hematopoiesis by ex vivo actived immune cells

Publications (3)

Publication Number Publication Date
JP2006514034A JP2006514034A (ja) 2006-04-27
JP2006514034A5 true JP2006514034A5 (cg-RX-API-DMAC7.html) 2006-06-22
JP4863620B2 JP4863620B2 (ja) 2012-01-25

Family

ID=29582827

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004562241A Expired - Fee Related JP4863620B2 (ja) 2002-05-29 2003-05-07 抹消血単核細胞の培養方法及び該細胞を用いた薬剤組成物

Country Status (6)

Country Link
US (3) US7048922B2 (cg-RX-API-DMAC7.html)
EP (2) EP2011863A1 (cg-RX-API-DMAC7.html)
JP (1) JP4863620B2 (cg-RX-API-DMAC7.html)
DE (1) DE60325967D1 (cg-RX-API-DMAC7.html)
ES (1) ES2321189T3 (cg-RX-API-DMAC7.html)
WO (1) WO2004056397A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7332158B2 (en) 2002-05-29 2008-02-19 Demao Yang Compositions and treatments for myelosuppression by ex vivo activated immune cells
US7048922B2 (en) * 2002-05-29 2006-05-23 Demao Yang Stimulation of hematopoiesis by ex vivo activated immune cells
WO2005003321A2 (en) * 2003-07-06 2005-01-13 Roger Williams Medical Center Methods of producing differentiated hematopoietic cells for treatment of cytopenia
JP2008512454A (ja) * 2004-09-10 2008-04-24 ヤング，デマオ 骨髄抑制患者に対する体外活性化細胞療法の構成と応用
US20060057121A1 (en) * 2004-09-10 2006-03-16 Demao Yang Compositions and treatments using ex vivo activated cells for myelosuppressed patients
US20080195007A1 (en) * 2007-02-12 2008-08-14 Yury Podrazhansky Method and device for using vibroacoustic stimulaton to enhance the production of adult stem cells in living organisms
GB0918615D0 (en) * 2009-10-23 2009-12-09 Cellerix Sa Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
CA2799516C (en) * 2010-08-06 2016-01-05 Canine-Lab.Inc. Immunological function enhancing agent
US8895291B2 (en) 2010-10-08 2014-11-25 Terumo Bct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
JP6633522B2 (ja) 2013-11-16 2020-01-22 テルモ ビーシーティー、インコーポレーテッド バイオリアクターにおける細胞増殖
CN106232800B (zh) 2014-03-25 2020-07-03 泰尔茂比司特公司 介质的被动替代
JP6830059B2 (ja) 2014-09-26 2021-02-17 テルモ ビーシーティー、インコーポレーテッド スケジュール化された細胞フィーディング
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
EP3464565A4 (en) 2016-05-25 2020-01-01 Terumo BCT, Inc. CELL EXPANSION
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
EP3656842A1 (en) 2017-03-31 2020-05-27 Terumo BCT, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US12458249B2 (en) * 2018-03-29 2025-11-04 Demao Yang Cell therapy for patients
JP7705950B2 (ja) 2021-03-23 2025-07-10 テルモ ビーシーティー、インコーポレーテッド 細胞を増殖する方法
US12152699B2 (en) 2022-02-28 2024-11-26 Terumo Bct, Inc. Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766920A (en) 1982-08-11 1998-06-16 Cellcor, Inc. Ex vivo activation of immune cells
US5047421A (en) 1984-01-26 1991-09-10 Oral-D Orally effective ion chelators
US5015664A (en) 1984-01-26 1991-05-14 Oral D Orally effective ion chelators related to deferoxamine
US5550161A (en) 1984-01-26 1996-08-27 Oral-D Substituted orally effective ION chelators related to deferoxamine
US6352694B1 (en) 1994-06-03 2002-03-05 Genetics Institute, Inc. Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
US5108760A (en) 1989-07-21 1992-04-28 Terumo Corporation Enhances lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides
US5525232A (en) 1990-03-02 1996-06-11 The Liposome Company, Inc. Method for entrapment of cationic species in lemellar vesicles
CA2133409C (en) 1992-04-01 2011-05-24 Ralph M. Steinman Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US5312831A (en) 1993-05-12 1994-05-17 American Cyanamid Company Urethanes and ureas that induce cytokine production
EP0641776A3 (en) 1993-09-08 1997-05-02 Takeda Chemical Industries Ltd Thioglycerol derivatives.
AU1524095A (en) 1994-01-27 1995-08-15 Cellcor, Inc. Ex vivo activation of immune cells
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
US5948820A (en) 1994-08-22 1999-09-07 Yoshitomi Pharmaceutical Industries, Ltd. Benzene compound and pharmaceutical use thereof
US6033661A (en) 1995-06-07 2000-03-07 Thomas Jefferson University Composition and method for allogenetic mononuclear cell immunotherapy
US5643786A (en) 1995-01-27 1997-07-01 The United States Of America As Represented By The Department Of Health And Human Services Method for isolating dendritic cells
US6010905A (en) * 1995-01-27 2000-01-04 The United States Of America As Represented By The Department Of Health & Human Services Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cells
US7067318B2 (en) * 1995-06-07 2006-06-27 The Regents Of The University Of Michigan Methods for transfecting T cells
US6008042A (en) 1996-05-16 1999-12-28 Smithkline Beecham Corporation Interleukin-1 beta converting enzyme like apoptotic protease-7
US6010878A (en) 1996-05-20 2000-01-04 Smithkline Beecham Corporation Interleukin-1 β converting enzyme like apoptotic protease-6
US5968513A (en) 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
AU4052197A (en) 1996-08-14 1998-03-06 Nexell Therapeutics Inc. Cytokine-free culture of dendritic cells
US6340461B1 (en) 1996-12-17 2002-01-22 David Stephen Terman Superantigen based methods and compositions for treatment of diseases
US6231880B1 (en) 1997-05-30 2001-05-15 Susan P. Perrine Compositions and administration of compositions for the treatment of blood disorders
US5932446A (en) 1997-08-18 1999-08-03 Smithkline Beecham Corporation Hmvab41
EP1021197B1 (en) 1997-10-10 2007-04-11 The Regents of the University of California Implants comprising combinations of allogeneic cells for use in cancer treatment
CA2322659A1 (en) * 1998-03-20 1999-09-23 Genzyme Corporation Compositions and methods for gene-based vaccines to provoke t cell responses
US6555374B1 (en) 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
WO2001034788A1 (en) 1999-11-10 2001-05-17 Yoreh Biotechnologies Ltd. In-vitro assay for assessment of cytotoxicity of a candidate agent
WO2001062092A1 (en) 2000-02-25 2001-08-30 Thomas Jefferson University Formulations and methods for using the same to elicit an immune response
AU2002218019A1 (en) 2000-11-03 2002-05-15 Nexell Therapeutics Inc. Methods for depleting and isolating alloreactive and antigen-reactive t cells from hematopoietic donor cells
US7745140B2 (en) * 2002-01-03 2010-06-29 The Trustees Of The University Of Pennsylvania Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
US7048922B2 (en) * 2002-05-29 2006-05-23 Demao Yang Stimulation of hematopoiesis by ex vivo activated immune cells
US7332158B2 (en) * 2002-05-29 2008-02-19 Demao Yang Compositions and treatments for myelosuppression by ex vivo activated immune cells

Similar Documents

Publication Publication Date Title
JP2006514034A5 (cg-RX-API-DMAC7.html)
JP2009137992A5 (cg-RX-API-DMAC7.html)
NZ593364A (en) Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
EP1731177A4 (en) BIOLOGICAL TISSUE SHEET, METHOD OF FORMATION THEREOF AND TRANSPLANTATION METHOD USING THE SHEET
BR0312365A (pt) Meio de cultura autólogo de células-mães progenitoras autólogas humanas, métodos para a preparação do mesmo e de uma composição de células-mães progenitoras autólogas humanas e para a obtenção de células-mães progenitoras musculares autólogas humanas, emprego de um meio de cultura autólogo de células-mães progenitoras autólogas humanas, procedimento para a obtenção de células-mães progenitoras musculares autólogas humanas e procedimento terapêutico de cardiomioplastia celular autóloga, composição enriquecida com células-mães progenitoras musculares autólogas humanas e composição farmacêutica
RU2006146795A (ru) Композиция для стимулирования роста и регенерации клеток, а также способы ее получения
DE60023673D1 (de) Dna-impfung zur behandlung von autoimmunerkrankungen
CN103421740A (zh) 一种人骨髓间充质干细胞体外培养扩增方法
CN103642859B (zh) 一种用于提高卷枝毛霉产γ-亚麻酸产量的发酵培养基及用途
CN109757300A (zh) 一种牛樟芝的培育方法及其在动物饲料中的应用
JP2011503137A5 (cg-RX-API-DMAC7.html)
JP2009517078A5 (cg-RX-API-DMAC7.html)
CN103755417B (zh) 一种富硒猴头菌菌丝体液体发酵的生产方法
CN103122334A (zh) 异育银鲫肠道上皮细胞的原代培养及纯化方法
CN108901598A (zh) 一种富硒灵芝的栽培方法
CN101869585B (zh) 用于辅助b型肝炎药物治疗效果的组合物
RU2004129179A (ru) Способ получения стимулятора роста озимой пшеницы
CN114099632A (zh) 一种中药发酵物及其在制备治疗真菌感染皮肤病药物上的应用
CN114208672A (zh) 一种蝴蝶兰组织培育用液体培养基
RU2399664C1 (ru) Способ определения продукции факторов хоминга стволовых клеток
CN112522196A (zh) 一种nk细胞培养基和应用
US20110213023A1 (en) Method for inhibiting production of cytokines of t helper cell type ii and/or inhibiting production of chemokines using brazilin
CN114288326B (zh) 一种杜氏杆菌在高盐饮食导致的血管疾病中的应用
CN108300667A (zh) 一种富硒蛹虫草发酵培养的方法
RU98119056A (ru) Способ моделирования пролиферативной витреоретинопатии